Tularemia: Report of 16 cases in the Castilla-León community;Tularemia: Descripción de 16 casos procedentes de la comunidad de Castilla-León

Revista Clinica Espanola

Volumn 198, Issue 12, 1998, Pages 794-798

  Montejo, M ^a   Perez Irezabal J ^a   Gonzalez De Zarate P ^a   Aguirrebengoa, K ^a   Vicente, J M ^a   Martinez E ^b   Ibarra, S ^a   Bereciartua, E ^a   Castell, C ^c  

^a HOSPITAL DE CRUCES   (Spain)

^b HOSPITAL DE GALDAKAO   (Spain)

^c U de Vigilancia Epidemiologica   (Spain)

Author keywords

Francisella tularensis; Tularemia; Ulceroglandular form

Indexed keywords

ADULT; ARTICLE; FEMALE; HUMAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; SPAIN; TULAREMIA; ANTIBIOTIC THERAPY; CLINICAL ARTICLE; DISEASE COURSE; FRANCISELLA TULARENSIS; REVIEW; SERODIAGNOSIS;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SPAIN; TULAREMIA;

AMOXICILLIN; AZITHROMYCIN; CIPROFLOXACIN; DOXYCYCLINE; STREPTOMYCIN; TOBRAMYCIN;

EID: 0032249601     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. a ed). Washington: Dic American Society for Microbiology, 1995; 545-548
2. a ed). New York: Churchill Livinstone, 1995; 2.060-2.068.
3. Evans ME, Gregory DW, Schaffner W, Mc Gee ZA. Tularemia: a 30 year experience with 88 cases. Medicine (Baltimore) 1985; 64:251-269.
4. Taylor JP, Istre GR, McChesney TC, Satalowich FC, Parker RL, McFarland LM. Epidemiologic characteristics of human tularemia in the south west-central states, 1981-1987. Am J Epidemiol 1991; 133:1.032-1.038.
5. Boletín Epidemiólogico Semanal (Instituto de Salud Carlos III). 1997; 5 (26): 249-252.
6. Syrjala H, Koskela P, Ripatti T, Salminen A, Herva E. Agglutination and ELISA methods in the diagnosis of tularemia in different clinical forms and severities of the disease. J Infect Dis 1986; 153:142-145.
7. Francis E. A summary of the present knowledge of tularemia. Medicine (Baltimore) 1928; 7:411-432.
8. Schmid GP, Kornblatt AN, Connors CA, et al. Clinically mild tularemia associated with mild tick-borne Francisella tularensis. J Infect Dis 1983; 148:63-67.
9. Ohara Y, Sato T, Fujita H, Ueno T, Homena M. Clinical manifestations of tularemia in Japan-analysis of 1355 cases observed between 1924 and 1987. Infection 1991; 19:14-17.
10. Cox SK, Everett ED. Tularemia. An analysis of 25 cases. MO Med 1981; 78:70-74.
11. Wills Pl, Gedosh EA, Nichols DR. Head and neck manifestations of tularemia. Laryngoscope 1982; 92:770-773.
12. Umlas SL, Jaramillo D. Massive adenopathy in oropharyngeal tularemia; CT demostration. Pediatr Radiol 1990; 20:483-484.
13. Marcus DM, Frederick AR Jr, Hodges T, Allan JD, Albert DM. Typhoidal tularemia. Arch Ophtalmol 1990; 108:118-119.
14. Centers for Disease Control Tularemia Pneumonia. Tennessee: MMWR 1983; 32:262-264, 269.
15. Van Metre TE Jr, Kadull PJ. Laboratory-acquired tularemia in vaccinated individuals; a report of 62 cases. Ann Intern Med 1959; 50:621-632.
16. Sunderrajan EV, Hutton J, Marienfels RD. Adult respiratory distress syndrome secondary to tularemia pneumonia. Arch Intern Med 1985; 145:1.435-1.437.
17. Miller RP, Bates JH. Pleuropulmonary tularemia. Am Rev Respir Dis 1969; 99:31-41.
18. Halsted CC, Kulasinghe HP. Tularemia pneumonia in urban children. Pediatrics 1978; 61:660-662.
19. Marione WJ, Marshall LW, Kaufman AF, Hobbs JH, Levy ME. Tularemia pneumonia in Washington, DC: a report of three cases with possible common-source exposures. JAMA 1979; 242:2.315-2.317.
20. Martin RE, Bates JH. Atypical pneumonia. Inffet Dis Clin North Am 1991; 5:585-601.
21. Jacobs RF, Condrey YM, Yamauchi T. Tularemia in adults and children. A changing presentation Pediatrics 1985; 76:818-822.
22. Kaiser AB, Rieves D, Price AH, et al. Tularemia and rhabdomyolisis. JAMA 1985; 253:241-242.
23. Reary BW, Klotz SA. Enhancing recovery of Francisella tularensis from blood. Diagn Microbiol Infect Dis 1988; 11:117-119.
24. Provenza MJ, Klotz SA, Penn RL. Isolation of Francisella tularensis from blood. J Clin Microbiol 1986; 24:453-455.
25. Bevanger L, Maeland JA, Naess AI. Aglutinins and antibodies to Francisella tularensis outer membrane antigens in the early diagnosis of disease during an outbreak of tularemia. J Clin Microbiol 1988; 26:433-437.
26. Sato T, Fujita H, Ohara Y, Homna M. Microagglutination test for early and specific serodiagnosis of tularemia. J Clin Microbiol 1990; 28:2.374-2.375.
27. Snyder MJ. Immune response to Francisella tularensis. En: Rose NR, Friedman H, Fabey JL, eels. Manual of clinical laboratory immunology Washington DC: American Society for Microbiology, 1986; 377-378.
28. Tärnvik A. Nature of protective immunity to Francisella tularensis. Rev Infect Dis 1989; 11:440-450.
29. Long GW, Oprandy JJ, Narayanan RB, Fortier AH, Porter KR, Nacy CA. Detection of Francisella tularensis in blood by polymerase chain reaction. J Clin Microbiol 1993; 31:152-154.
30. Forsman M, Kuoppa K, Sjöstedt A, Taruvik A. Use of RNA hybridization in the diagnosis of a case of ulceroglandular tularemia. Eur J Clin Microbiol Infect Dis 1990; 9:784-785.
31. Enderlin G, Morales L, Jacobs RF, Cross JT. Streptomycin and alternative agents for the treatment of tularemia. Review of the literature. Clin Infect Dis 1994; 19:42-47.
32. Risi GF, Pombo DJ. Relapse of tularemia after aminoglycoside therapy: case report and discussion of therapeutic options. Clin Infect Dis 1995; 20:174-175.
33. Scheel O, Reiersen R, Hotel T. Treatment of tularemia with ciprofloxacina. Eur J Clin Microbiol Infect Dis 1992; 84:1.277-1.278.
34. Syrjäla H, Schildt TR, Räisäinem S. In vivo susceptibility of Francisella tularensis to fluoroquinolones and treatment of tularemia with norfloxacin and ciprofloxacin. Eur J Clin Microbiol Infect Dis 1991; 10:68-70.
35. Harrel RE Jr, Simmons HF. Pleuropulmonary tularemia: successfull treatment with erythromycin. South Med J 1990; 83:1.363-1.364.
36. Lee HC, Horowitz E, Linder W. Treatment of tularemia with imipenem-cilastatina sodium. Soth Med J 1991; 84:1.277-1.278.
37. Cross JT, Jacobs RF. Tularemia: treatment failures outpatient use of ceftriaxone. Clin Infect Dis 1993; 17:976-980.
38. Penn RL, Kinasewitz GT. Factors associated with a poor outcome in tularemia. Arch Intern Med 1987; 147:265-268.
39. Burke DS. Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia. J Infect Dis 1977; 135:55-60.
40. Sawyer WD, Dangerfield HG, Hogge AL, Crozier D. Antibiotic prophylaxis and therapy of airbone tularemia. Bacteriol Rev 1966; 30: 542-548.